(Q33387767)

26 July 2017

1 reference

title

Thrombotic thrombocytopenic purpura: recognition and management (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

Joseph E Kiss

1

1 reference

26 July 2017

publication date

1 January 2010

1 reference

International Journal of Hematology

26 July 2017

published in

1 reference

26 July 2017

volume

91

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

36-45

1 reference

Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-009-0478-Z

Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-009-0478-Z

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-009-0478-Z

Treatment of thrombotic thrombopenic purpura. Results of a multicenter randomized clinical study

21 January 2018

1 reference

12 December 2020

Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison

1 reference

12 December 2020

Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry

1 reference

12 December 2020

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

1 reference

12 December 2020

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

1 reference

12 December 2020

United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange

1 reference

12 December 2020

Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasma therapy in one patient with hemolytic-uremic syndrome

1 reference

12 December 2020

Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders

1 reference

12 December 2020

Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

12 December 2020

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

12 December 2020

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

1 reference

12 December 2020

Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies

1 reference

12 December 2020

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine

1 reference

12 December 2020

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

12 December 2020

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

12 December 2020

Thrombotic microangiopathy in transplantation and malignancy

1 reference

12 December 2020

Adult hemolytic-uremic syndrome. A review of 37 cases

1 reference

12 December 2020

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

1 reference

12 December 2020

The management of thrombotic thrombocytopenic purpura in 2005.

1 reference

12 December 2020

A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab

1 reference

12 December 2020

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.

1 reference

12 December 2020

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

From the bench to the bedside: ways to improve rituximab efficacy.

1 reference

12 December 2020

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

12 December 2020

Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state

1 reference

12 December 2020

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement

1 reference

12 December 2020

HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study

1 reference

12 December 2020

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity

1 reference

12 December 2020

Comparison and stability of ADAMTS13 activity in therapeutic plasma products

1 reference

12 December 2020

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Management of a patient with HIV infection-induced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature

1 reference

12 December 2020

Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

12 December 2020

Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy

1 reference

12 December 2020

Treatment of thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Clinical practice. Thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

1 reference

12 December 2020

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

TTP and ADAMTS13: When Is Testing Appropriate?

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy

1 reference

12 December 2020

Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy

1 reference

12 December 2020

Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution

1 reference

12 December 2020

Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008

1 reference

12 December 2020

High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients

1 reference

12 December 2020

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

1 reference

12 December 2020

Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura

1 reference

12 December 2020

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

12 December 2020

An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Drug-induced thrombotic microangiopathy

1 reference

12 December 2020

Thrombotic microangiopathies: towards a pathophysiology-based classification

1 reference

12 December 2020

Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP.

1 reference

12 December 2020

An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura

1 reference

12 December 2020

Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features

1 reference

12 December 2020

Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases

1 reference

12 December 2020

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Cancer awareness in atypical thrombotic microangiopathies

1 reference

12 December 2020

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

1 reference

12 December 2020

Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients

1 reference

12 December 2020

10.1007/S12185-009-0478-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1046431999

0 references

1 reference